Investing Profile

Jasper Bos

InvestorVC
General Partner at Forbion
forbion.comAmsterdam, Netherlands
Photo of Jasper Bos, General Partner at Forbion
Your Intro Paths to Jasper Bos

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Jasper Bos on

cb
Current Investing Position
Forbion General Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
10

Jasper Bos is on these Sector & Stage Rankings

Jasper Bos's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Engrail Therapeutics
Series BMar 2024$160M
$220M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Peter Bisgaard (Pivotal bioVenture Partners), Niall O’Donnell (RiverVest), Heath Lukatch (Red Tree Venture Capital)
Precirix
Series BMar 2022$88M
$130M
Co-investors: Marten Steen (HealthCap), Ohad Hammer (Pontifax Venture Capital), Simone Botti (INKEF Capital)
Anaveon
Series BDec 2021$120M
$160M
Co-investors: Florian Müllershausen (Novartis Venture Fund), Ohad Hammer (Pontifax Venture Capital), Denis Patrick (Pfizer Venture Investments)
Inthera Bioscience
Series AJun 2018$5M
Series AMay 2017$11M
SeedDec 2015$4M
$20M
Co-investors: Mark Krul (Aglaia BioMedical Ventures), Keno Gutierrez (BGV (BioGeneration Ventures)), Nanna Luneborg (Forbion)
Prexton Therapeutics
Series BFeb 2017$31M
Series AFeb 2015$10M
$41M
Co-investors: Alan O'Connell (Seroba Life Sciences), Marco Boorsma (Forbion)
ARTSaVIT
Series AJan 2017$6M
$6M
Metabomed
Series AApr 2016$18M
$18M